The IL-4Rα Q576R polymorphism is associated with increased severity of atopic dermatitis and exaggerates allergic skin inflammation in mice
Barbara Yang(Brigham and Women's Hospital), Raif S. Geha(Boston Children's Hospital), Kathleen C. Barnes(Johns Hopkins University), Donald Y.M. Leung(Boston Children's Hospital), Michelle Daya(University of Colorado Denver), Hani Harb(Worldwide Universities Network), Wanda Phipatanakul(Boston Children's Hospital), Brian Woods(Boston Children's Hospital), Maheshwor Timilshina(Boston Children's Hospital), Rasika A. Mathias(Johns Hopkins University), Carter R. Petty(Boston Children's Hospital), Talal A. Chatila(Boston Children's Hospital), Wayne Bainter(Boston Children's Hospital), Hazel Wilkie(Boston Children's Hospital), Peggy S. Lai(Harvard University), Lisa A. Beck(University of Rochester Medicine), Tissa Hata(University of California San Diego), Mrinmoy Das(Sorbonne Université), Eric L. Simpson(Oregon Health & Science University), Juan Manuel Leyva-Castillo(Boston Children's Hospital), Meher Preethi Boorgula(University of Colorado Anschutz Medical Campus), Edie Weller(Boston Children's Hospital)
Cited by 21
Related Papers
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k
Guidelines of care for the management of atopic dermatitis
|Journal of the American Academy of Dermatology|2013|1.3k